在轻度阿尔茨海默病中使用拉罗美斯特罗塞尔的异构介质干细胞疗法:一个随机对照的2a期随机试验
Brian G Rash1, Kevin N Ramdas2, Nataliya Agafonova2
1Longeveron, Miami, FL, USA. brash@longeveron.com.
Nature medicine
|March 11, 2025
概括
拉罗梅斯特罗塞尔是一种干细胞疗法,在阿尔茨海默病 (AD) 的2a期试验中证明了安全性和潜在疗效. 它减缓了大脑缩和神经炎症,在阿尔茨海默病患者中显示出对认知功能有希望.
科学领域:
- 神经学 神经学
- 再生医学是一种再生医学.
- 临床试验 临床试验
背景情况:
- 阿尔茨海默病 (AD) 涉及渐进的认知衰退,大脑缩和神经炎症.
- 目前的治疗方法在阻止疾病进展方面有效性有限.
研究的目的:
- 为了评估laromestrocel的安全性和有效性,一个全源性介质干细胞疗法,在患有轻度阿尔茨海默病的患者中.
- 评估laromestrocel对临床进展,大脑缩和神经炎症的影响.
主要方法:
- 一个随机,双盲,安慰剂控制,并行组2a期临床试验.
- 在39周内,参与者每月接受安慰剂,2500万细胞或1亿细胞输注.
- 通过治疗出现的严重不良事件来评估安全性;通过临床评估,大脑体积变化和神经炎症标志物来评估有效性.
主要成果:
- 该研究满足了其主要安全终点,所有组的不良事件发生率相似.
- 与安慰剂相比,拉罗梅斯特罗塞尔治疗显示了认知评估和AD复合得分的改善.
- 观察到全脑和海马体积下降的显著减缓,以及神经炎症的减少.
结论:
- 在轻度AD患者中,拉罗梅斯特罗塞尔单剂和多剂安全.
- 该疗法在减少大脑缩和潜在地改善认知功能方面显示出有效性的迹象.
- 需要进行更大规模的临床试验,以进一步调查laromestrocel用于阿尔茨海默病治疗.
相关概念视频
Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...


